VIDEO: Surface Ophthalmics updates dry eye, post-cataract pain and inflammation candidates

ByKamran Hosseini, MD, PhD

ByDavid W. Mullin

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

NEWPORT BEACH, Calif. — In this Healio Video Perspective, Kamran Hosseini, MD, PhD, CEO of Surface Ophthalmics, discusses the clinical trial progress of its dry eye and post-cataract surgery pain and inflammation candidates.

Published by:

Sources/Disclosures

Collapse

Source:

Healio Interviews

Disclosures: Hosseini reports being CEO of Surface Ophthalmics.

Read more about

inflammation

dry eye disease

ophthalmic business

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

• Facebook
• Twitter
• LinkedIn
• Email
• Print
• Comment